CN111991266A - 一种润燥保湿霜及其制备方法 - Google Patents
一种润燥保湿霜及其制备方法 Download PDFInfo
- Publication number
- CN111991266A CN111991266A CN202011040730.6A CN202011040730A CN111991266A CN 111991266 A CN111991266 A CN 111991266A CN 202011040730 A CN202011040730 A CN 202011040730A CN 111991266 A CN111991266 A CN 111991266A
- Authority
- CN
- China
- Prior art keywords
- percent
- phase
- moisturizing cream
- skin
- moisturizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 52
- 239000006071 cream Substances 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 102000016942 Elastin Human genes 0.000 claims abstract description 10
- 108010014258 Elastin Proteins 0.000 claims abstract description 10
- 229920002549 elastin Polymers 0.000 claims abstract description 10
- 239000003974 emollient agent Substances 0.000 claims abstract description 7
- 239000003906 humectant Substances 0.000 claims abstract description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 7
- 239000004094 surface-active agent Substances 0.000 claims abstract description 7
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 5
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 5
- 229940106189 ceramide Drugs 0.000 claims abstract description 5
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 5
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000011734 sodium Substances 0.000 claims abstract description 5
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- -1 polydimethylsiloxane Polymers 0.000 claims description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 12
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 12
- MDYOLVRUBBJPFM-UHFFFAOYSA-N tropolone Chemical compound OC1=CC=CC=CC1=O MDYOLVRUBBJPFM-UHFFFAOYSA-N 0.000 claims description 12
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 claims description 10
- IHRKJQSLKLYWBQ-QKDODKLFSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O IHRKJQSLKLYWBQ-QKDODKLFSA-N 0.000 claims description 6
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 claims description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 6
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 6
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims description 6
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims description 6
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 6
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 6
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 6
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 claims description 6
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 6
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 6
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 6
- 239000005642 Oleic acid Substances 0.000 claims description 6
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 6
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 235000021355 Stearic acid Nutrition 0.000 claims description 6
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 6
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 6
- 229960003237 betaine Drugs 0.000 claims description 6
- 229960001631 carbomer Drugs 0.000 claims description 6
- 229940073669 ceteareth 20 Drugs 0.000 claims description 6
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 6
- 229960000541 cetyl alcohol Drugs 0.000 claims description 6
- 229940074979 cetyl palmitate Drugs 0.000 claims description 6
- 235000012000 cholesterol Nutrition 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- 229960005188 collagen Drugs 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 6
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 229940075529 glyceryl stearate Drugs 0.000 claims description 6
- 229940049294 glyceryl stearate se Drugs 0.000 claims description 6
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims description 6
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 6
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 6
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 229960000448 lactic acid Drugs 0.000 claims description 6
- 229940071085 lauroyl glutamate Drugs 0.000 claims description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 6
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 6
- 229960002969 oleic acid Drugs 0.000 claims description 6
- 229940093441 palmitoyl oligopeptide Drugs 0.000 claims description 6
- 229940094946 palmitoyl tetrapeptide-7 Drugs 0.000 claims description 6
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 6
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 claims description 6
- 229940033329 phytosphingosine Drugs 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 6
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 6
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- 229940068977 polysorbate 20 Drugs 0.000 claims description 6
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims description 6
- 229940032094 squalane Drugs 0.000 claims description 6
- 239000008117 stearic acid Substances 0.000 claims description 6
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 6
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical group OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 5
- 229920002126 Acrylic acid copolymer Polymers 0.000 claims description 5
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims description 5
- 229940044176 ceramide 3 Drugs 0.000 claims description 5
- 239000003086 colorant Substances 0.000 claims description 5
- 229920013818 hydroxypropyl guar gum Polymers 0.000 claims description 5
- 229960005323 phenoxyethanol Drugs 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 claims description 5
- WHBKVWBGTBULQY-UHFFFAOYSA-N 2-propylheptyl octanoate Chemical compound CCCCCCCC(=O)OCC(CCC)CCCCC WHBKVWBGTBULQY-UHFFFAOYSA-N 0.000 claims description 4
- 241000195619 Euglena gracilis Species 0.000 claims description 4
- KIUVQMGRTDPAFR-UHFFFAOYSA-N benzoic acid 2-hydroxy-2-phenylpropanamide Chemical compound C(C1=CC=CC=C1)(=O)O.OC(C(=O)N)(C)C1=CC=CC=C1 KIUVQMGRTDPAFR-UHFFFAOYSA-N 0.000 claims description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 4
- 229940042585 tocopherol acetate Drugs 0.000 claims description 4
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 claims description 3
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 3
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 3
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 3
- 241000218631 Coniferophyta Species 0.000 claims description 3
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 3
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 3
- 229960004274 stearic acid Drugs 0.000 claims description 3
- VKIJBOMCWLTQBD-UHFFFAOYSA-N benzoic acid N-(2-hydroxyphenyl)propanamide Chemical group C(C1=CC=CC=C1)(=O)O.C(CC)(=O)NC1=C(C=CC=C1)O VKIJBOMCWLTQBD-UHFFFAOYSA-N 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000003750 conditioning effect Effects 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- GHJOIQFPDMIKHT-UHFFFAOYSA-N propane-1,2,3-triol;prop-2-enoic acid Chemical compound OC(=O)C=C.OCC(O)CO GHJOIQFPDMIKHT-UHFFFAOYSA-N 0.000 claims description 2
- 229960004106 citric acid Drugs 0.000 claims 1
- 230000037067 skin hydration Effects 0.000 abstract description 6
- 230000037336 dry skin Effects 0.000 abstract description 3
- 230000032683 aging Effects 0.000 abstract description 2
- 230000007812 deficiency Effects 0.000 abstract description 2
- 230000037307 sensitive skin Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 10
- 230000001804 emulsifying effect Effects 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000011449 brick Substances 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000276425 Xiphophorus maculatus Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- OQBIVESRYIWBPL-UHFFFAOYSA-N decan-4-yl octanoate Chemical compound CCCCCCCC(=O)OC(CCC)CCCCCC OQBIVESRYIWBPL-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种润燥保湿霜及其制备方法,该润燥保湿霜包含以下按质量百分比计的组分:皮肤调理剂2%~22%、润肤剂3%~22%、保湿剂5%~17%、表面活性剂2.5%~9%、赋形剂1.1%~5%、PCA钠0.01%~1%、水解弹性蛋白0.05%~3%、神经酰胺30.02%~2%。本发明提供的润燥保湿霜锁水保湿效果优异,能强化肌肤修护能力,明显改善肌肤缺水老化,并提高肌肤的水合能力,改善干燥、脱皮、干敏的肌肤。
Description
技术领域
本发明属于化妆品领域,具体涉及一种润燥保湿霜及其制备方法。
背景技术
皮肤的水合保湿是维持皮肤结构完整性和屏障功能的重要因素。皮肤的屏障功能有赖于角质层成分的“砖和灰浆”结构,角质形成细胞好比是砖,成叠的板状脂质(细胞间质)好比砌墙的灰浆。它们严密牢固的连接起来,防止水分及电解质过度流失,另一方面可阻止外界有害物质的入侵,起到良好的皮肤屏障的作用。天然保湿因子是角质形成细胞内或细胞外具有吸湿性分子的总称,主要有氨基酸及其衍生物及乳酸盐类、尿素及电解质类,对保持角质细胞及角质层的水合亦有重要作用。角质层含水量占表皮的20%~35%,低于10%皮肤就会干燥、粗糙、脱屑。角质层水分不仅是角质层成熟作用及正常脱屑所必须的,而且经皮水分过多的丢失会损伤正常脱屑所需酶类从而导致肉眼可见的干燥、粗糙、鳞屑等外观。因此,干燥肌肤不仅是简单的皮肤缺水,而是角质层需水过程不能正常进行的功能异常。皮肤含水量是决定皮肤健康状况的主要指标。因此,保湿是化妆品永恒的主题,保湿化妆品也成为广大消费者所关注的重点。因此,研发一款润燥保湿霜尤为重要。
发明内容
为了满足消费者对保湿效果的需求,本发明第一个方面的目的,在于提供一种润燥保湿霜。
本发明的第二方面的目的,在于提供一种润燥保湿霜的制备方法。
为了实现上述目的,本发明所采取的技术方案是:
本发明的第一个方面,提供一种润燥保湿霜,优选包含以下按质量百分比计的组分:皮肤调理剂2%~22%、润肤剂3%~22%、保湿剂5%~17%、表面活性剂2.5%~9%、赋形剂1.1%~5%、PCA钠0.01%~1%、水解弹性蛋白0.05%~3%、神经酰胺30.02%~2%;更优选包含以下按质量百分比计的组分:皮肤调理剂13.8625%~21.3225%、润肤剂14.2%~21%、保湿剂10.2%~16.5%、表面活性剂5.2%~8.5%、赋形剂2.2%~3.4%、PCA钠0.2%~0.5%、水解弹性蛋白0.3%~1%、神经酰胺3 0.5%~0.8%。
所述润燥保湿霜还包含:防腐剂、芳香剂和着色剂中的至少一种与水。
所述防腐剂、芳香剂和着色剂的用量为适量,符合国家、行业等相关规定。
所述水的用量为余量。
所述皮肤调理剂优选为甘油丙烯酸酯/丙烯酸共聚物、丙二醇、植物甾醇/辛基十二醇月桂酰谷氨酸酯、生育酚乙酸酯、柠檬酸、环庚三烯酚酮、聚山梨醇酯-20、乙基己基甘油、1,2-己二醇、羟苯基丙酰胺苯甲酸、抗坏血酸棕榈酸酯、1,2-戊二醇、甘草酸二钾、EDTA二钠、细小裸藻多糖、水解胶原、卡波姆、棕榈酰寡肽、棕榈酰四肽-7、乳酸、辛酸/癸酸甘油三酯、胆甾醇、氢化卵磷脂、植物鞘氨醇和油酸中的至少一种;更优选为甘油丙烯酸酯/丙烯酸共聚物、丙二醇、植物甾醇/辛基十二醇月桂酰谷氨酸酯、生育酚乙酸酯、柠檬酸、环庚三烯酚酮、聚山梨醇酯-20、乙基己基甘油、1,2-己二醇、羟苯基丙酰胺苯甲酸、抗坏血酸棕榈酸酯、1,2-戊二醇、甘草酸二钾、EDTA二钠、细小裸藻多糖、水解胶原、卡波姆、棕榈酰寡肽、棕榈酰四肽-7、乳酸、辛酸/癸酸甘油三酯、胆甾醇、氢化卵磷脂、植物鞘氨醇和油酸。
所述润肤剂优选为异硬脂醇异硬脂酸酯、辛酸丙基庚酯、聚二甲基硅氧烷、硬脂酸和角鲨烷中的至少一种;更优选为异硬脂醇异硬脂酸酯、辛酸丙基庚酯、聚二甲基硅氧烷、硬脂酸和角鲨烷。
所述保湿剂优选为甘油、双丙甘醇、丁二醇、甜菜碱和辛甘醇中的至少一种;更优选为甘油、双丙甘醇、丁二醇、甜菜碱和辛甘醇。
所述表面活性剂优选为甘油硬脂酸酯SE、甘油硬脂酸酯、鲸蜡硬脂醇聚醚-20、鲸蜡硬脂醇聚醚-12、鲸蜡硬脂醇、鲸蜡醇棕榈酸酯和鲸蜡醇磷酸酯钾中的至少一种;更优选为甘油硬脂酸酯SE、甘油硬脂酸酯、鲸蜡硬脂醇聚醚-20、鲸蜡硬脂醇聚醚-12、鲸蜡硬脂醇、鲸蜡醇棕榈酸酯和鲸蜡醇磷酸酯钾。
所述赋形剂优选为鲸蜡醇和羟丙基瓜儿胶中的至少一种;更优选为鲸蜡醇和羟丙基瓜儿胶。
所述防腐剂优选为苯氧乙醇。
所述芳香剂为香精。
所述着色剂优选为CI 75470、CI 15985和CI 42090中的至少一种;更优选为CI75470、CI 15985和CI 42090。
本发明的第二方面,提供一种润燥保湿霜的制备方法,步骤如下:
(1)取A相混合,溶解,得到A溶液;取B相混合,溶解,得到B溶液;
(2)将B溶液加入A溶液中,混合,得到AB混合物;
(3)向AB混合物中加入C相,混合,得到ABC混合物;
(4)向ABC混合物中加入D相、E相、F相、G相,混合,得到润燥保湿霜;
所述A相为甘油丙烯酸酯/丙烯酸共聚物、丙二醇、1,2-己二醇、1,2-戊二醇、甘草酸二钾、EDTA二钠、卡波姆、甘油、双丙甘醇、丁二醇、甜菜碱、辛甘醇、羟丙基瓜儿胶、水;
所述B相为植物甾醇/辛基十二醇月桂酰谷氨酸酯、生育酚乙酸酯、环庚三烯酚酮、聚山梨醇酯-20、植物鞘氨醇、油酸、乙基己基甘油、辛酸/癸酸甘油三酯、胆甾醇、氢化卵磷脂、异硬脂醇异硬脂酸酯、辛酸丙基庚酯、聚二甲基硅氧烷、硬脂酸、角鲨烷、甘油硬脂酸酯SE、甘油硬脂酸酯、鲸蜡硬脂醇聚醚-20、鲸蜡硬脂醇聚醚-12、鲸蜡硬脂醇、鲸蜡醇棕榈酸酯、鲸蜡醇磷酸酯钾、鲸蜡醇;
所述C相为苯氧乙醇;
所述D相为柠檬酸;
所述E相为羟苯基丙酰胺苯甲酸、抗坏血酸棕榈酸酯、细小裸藻多糖、水解胶原、棕榈酰寡肽、棕榈酰四肽-7、乳酸、PCA钠、神经酰胺3、水解弹性蛋白;
所述F相为香精;
所述G相为CI 42090、CI 75470、CI 15985。
步骤(1)中所述A相和B相的溶解的温度为80~90℃。
步骤(3)中加入C相时,所述AB混合物的温度为55~70℃。
步骤(4)中加入D相、E相、F相、G相时,所述ABC混合物的温度为40~50℃。
本发明的有益效果是:
本发明提供的润燥保湿霜锁水保湿效果优异,能强化肌肤修护能力,明显改善肌肤缺水老化,并提高肌肤的水合能力,改善干燥、脱皮、干敏的肌肤,令肌肤滋润健康,焕发柔嫩光彩。
本发明提供的润燥保湿霜中的PCA钠可作为肌肤的“加湿器”,补充所需水分;神经酰胺3可以修护肌肤,平衡肌肤水油平衡状态;水解弹性蛋白可以提升紧致度,赋予肌肤弹性。
具体实施方式
以下通过具体的实施例对本发明的内容作进一步详细的说明。
本实施例中所采用的原料,除特殊说明外,均通过常规手段制备或者通过商业渠道购买。
本实施例中所采用的处理方法均为本领域的常规技术手段。
实施例1~3和对比例1~3的润燥保湿霜配方如表1所示。
实施例1~3的润燥保湿霜的制备方法如下:
(1)取A相(甘油丙烯酸酯/丙烯酸共聚物、丙二醇、1,2-己二醇、1,2-戊二醇、甘草酸二钾、EDTA二钠、卡波姆、甘油、双丙甘醇、丁二醇、甜菜碱、辛甘醇、羟丙基瓜儿胶、水)于乳化锅,加热至80℃,溶解;
(2)取B(植物甾醇/辛基十二醇月桂酰谷氨酸酯、生育酚乙酸酯、环庚三烯酚酮、聚山梨醇酯-20、植物鞘氨醇、油酸、乙基己基甘油、辛酸/癸酸甘油三酯、胆甾醇、氢化卵磷脂、异硬脂醇异硬脂酸酯、辛酸丙基庚酯、聚二甲基硅氧烷、硬脂酸、角鲨烷、甘油硬脂酸酯SE、甘油硬脂酸酯、鲸蜡硬脂醇聚醚-20、鲸蜡硬脂醇聚醚-12、鲸蜡硬脂醇、鲸蜡醇棕榈酸酯、鲸蜡醇磷酸酯钾、鲸蜡醇)相于容器中,加热至80℃,溶解;
(3)将步骤(2)中溶解的B相加入步骤(1)中A相乳化锅中,匀质混合;
(4)60℃下向乳化锅中加入C相(苯氧乙醇),搅拌均匀;
(5)45℃下向乳化锅中加入D相(柠檬酸)、E相(羟苯基丙酰胺苯甲酸、抗坏血酸棕榈酸酯、细小裸藻(EUGLENA GRACILIS)多糖、水解胶原、棕榈酰寡肽、棕榈酰四肽-7、乳酸、PCA钠、神经酰胺3、水解弹性蛋白)、F相(香精)、G相(CI 42090、CI 75470、CI 15985),搅拌均匀即得润燥保湿霜。
对比例1的润燥保湿霜的制备方法与实施例1的润燥保湿霜的制备方法一致,区别仅在于不添加PCA钠。
对比例2的润燥保湿霜的制备方法与实施例1的润燥保湿霜的制备方法一致,区别仅在于不添加神经酰胺3。
对比例3的润燥保湿霜的制备方法与实施例1的润燥保湿霜的制备方法一致,区别仅在于不添加水解弹性蛋白。
表1实施例1~3和对比例1~3的润燥保湿霜的配方
效果实施例
1)锁水保湿效果测试:
选取24位年龄18~35岁、皮肤水合度接近的志愿者,均分为6组,测定每组志愿者初始的皮肤水合度(取平均值),再分别使用实施例1~3和对比例1~3的润燥保湿霜,每天一次,持续4周,再测试每组志愿者的皮肤水合度(取平均值),评价润燥保湿霜的锁水保湿效果,测试结果如表2所示:本发明提供的润燥保湿霜的锁水保湿效果优于对比例提供的润燥保湿霜。
表2锁水保湿效果测试结果
实施例1 | 实施例2 | 实施例3 | 对比例1 | 对比例2 | 对比例3 | |
0周 | 62 | 61 | 60 | 62 | 60 | 59 |
4周 | 78 | 81 | 71 | 72 | 70 | 70 |
注:皮肤水合度采用Cortex Technology公司生产的皮肤弹性测试仪进行测试。
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。
Claims (10)
1.一种润燥保湿霜,其特征在于,包含以下按质量百分比计的组分:皮肤调理剂2%~22%、润肤剂3%~22%、保湿剂5%~17%、表面活性剂2.5%~9%、赋形剂1.1%~5%、PCA钠0.01%~1%、水解弹性蛋白0.05%~3%、神经酰胺30.02%~2%。
2.根据权利要求1所述的润燥保湿霜,其特征在于:所述润燥保湿霜包含以下按质量百分比计的组分:皮肤调理剂13.8625%~21.3225%、润肤剂14.2%~21%、保湿剂10.2%~16.5%、表面活性剂5.2%~8.5%、赋形剂2.2%~3.4%、PCA钠0.2%~0.5%、水解弹性蛋白0.3%~1%、神经酰胺30.5%~0.8%。
3.根据权利要求1或2所述的润燥保湿霜,其特征在于:所述皮肤调理剂为甘油丙烯酸酯/丙烯酸共聚物、丙二醇、植物甾醇/辛基十二醇月桂酰谷氨酸酯、生育酚乙酸酯、柠檬酸、环庚三烯酚酮、聚山梨醇酯-20、乙基己基甘油、1,2-己二醇、羟苯基丙酰胺苯甲酸、抗坏血酸棕榈酸酯、1,2-戊二醇、甘草酸二钾、EDTA二钠、细小裸藻多糖、水解胶原、卡波姆、棕榈酰寡肽、棕榈酰四肽-7、乳酸、辛酸/癸酸甘油三酯、胆甾醇、氢化卵磷脂、植物鞘氨醇和油酸中的至少一种。
4.根据权利要求1或2所述的润燥保湿霜,其特征在于:所述润肤剂为异硬脂醇异硬脂酸酯、辛酸丙基庚酯、聚二甲基硅氧烷、硬脂酸和角鲨烷中的至少一种。
5.根据权利要求1或2所述的润燥保湿霜,其特征在于:所述保湿剂为甘油、双丙甘醇、丁二醇、甜菜碱和辛甘醇中的至少一种。
6.根据权利要求1或2所述的润燥保湿霜,其特征在于:所述表面活性剂为甘油硬脂酸酯SE、甘油硬脂酸酯、鲸蜡硬脂醇聚醚-20、鲸蜡硬脂醇聚醚-12、鲸蜡硬脂醇、鲸蜡醇棕榈酸酯和鲸蜡醇磷酸酯钾中的至少一种。
7.根据权利要求1或2所述的润燥保湿霜,其特征在于:所述赋形剂为鲸蜡醇和羟丙基瓜儿胶中的至少一种。
8.根据权利要求1或2所述的润燥保湿霜,其特征在于,
所述润燥保湿霜还包含:防腐剂、芳香剂和着色剂中的至少一种与水。
9.根据权利要求8所述的润燥保湿霜,其特征在于:
所述防腐剂为苯氧乙醇;
所述芳香剂为香精;
所述着色剂为CI 75470、CI 15985和CI 42090中的至少一种。
10.一种润燥保湿霜的制备方法,其特征在于,步骤如下:
(1)取A相混合,溶解,得到A溶液;取B相混合,溶解,得到B溶液;
(2)将B溶液与A溶液混合,得到AB混合物;
(3)将AB混合物与C相混合,得到ABC混合物;
(4)将ABC混合物与D相、E相、F相、G相混合,得到润燥保湿霜;
所述A相为甘油丙烯酸酯/丙烯酸共聚物、丙二醇、1,2-己二醇、1,2-戊二醇、甘草酸二钾、EDTA二钠、卡波姆、甘油、双丙甘醇、丁二醇、甜菜碱、辛甘醇、羟丙基瓜儿胶、水;所述B相为植物甾醇/辛基十二醇月桂酰谷氨酸酯、生育酚乙酸酯、环庚三烯酚酮、聚山梨醇酯-20、植物鞘氨醇、油酸、乙基己基甘油、辛酸/癸酸甘油三酯、胆甾醇、氢化卵磷脂、异硬脂醇异硬脂酸酯、辛酸丙基庚酯、聚二甲基硅氧烷、硬脂酸、角鲨烷、甘油硬脂酸酯SE、甘油硬脂酸酯、鲸蜡硬脂醇聚醚-20、鲸蜡硬脂醇聚醚-12、鲸蜡硬脂醇、鲸蜡醇棕榈酸酯、鲸蜡醇磷酸酯钾、鲸蜡醇;
所述C相为苯氧乙醇;
所述D相为柠檬酸;
所述E相为羟苯基丙酰胺苯甲酸、抗坏血酸棕榈酸酯、细小裸藻多糖、水解胶原、棕榈酰寡肽、棕榈酰四肽-7、乳酸、PCA钠、神经酰胺3、水解弹性蛋白;
所述F相为香精;
所述G相为CI 42090、CI 75470、CI 15985。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011040730.6A CN111991266A (zh) | 2020-09-28 | 2020-09-28 | 一种润燥保湿霜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011040730.6A CN111991266A (zh) | 2020-09-28 | 2020-09-28 | 一种润燥保湿霜及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111991266A true CN111991266A (zh) | 2020-11-27 |
Family
ID=73475420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011040730.6A Pending CN111991266A (zh) | 2020-09-28 | 2020-09-28 | 一种润燥保湿霜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111991266A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113069382A (zh) * | 2021-04-19 | 2021-07-06 | 李树玲 | 一种活肤霜 |
CN113197801A (zh) * | 2021-04-21 | 2021-08-03 | 安婕妤化妆品科技股份有限公司 | 一种保湿、抗炎、抗衰老乳液及其制备方法 |
CN113855610A (zh) * | 2021-10-25 | 2021-12-31 | 合肥工业大学智能制造技术研究院 | 一种原花青素黄精润肤保湿霜的制作方法 |
CN114939077A (zh) * | 2021-06-01 | 2022-08-26 | 安婕妤化妆品科技股份有限公司 | 一种胶原保湿润肤霜 |
CN115040434A (zh) * | 2021-07-01 | 2022-09-13 | 广州市科能化妆品科研有限公司 | 皮肤修护特护霜及其制备方法 |
-
2020
- 2020-09-28 CN CN202011040730.6A patent/CN111991266A/zh active Pending
Non-Patent Citations (1)
Title |
---|
安婕妤化妆品科技股份有限公司: "安婕妤弹力水嫩精华日霜", 《国产非特殊用途化妆品备案信息服务平台》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113069382A (zh) * | 2021-04-19 | 2021-07-06 | 李树玲 | 一种活肤霜 |
CN113197801A (zh) * | 2021-04-21 | 2021-08-03 | 安婕妤化妆品科技股份有限公司 | 一种保湿、抗炎、抗衰老乳液及其制备方法 |
CN114939077A (zh) * | 2021-06-01 | 2022-08-26 | 安婕妤化妆品科技股份有限公司 | 一种胶原保湿润肤霜 |
CN115040434A (zh) * | 2021-07-01 | 2022-09-13 | 广州市科能化妆品科研有限公司 | 皮肤修护特护霜及其制备方法 |
CN113855610A (zh) * | 2021-10-25 | 2021-12-31 | 合肥工业大学智能制造技术研究院 | 一种原花青素黄精润肤保湿霜的制作方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111991266A (zh) | 一种润燥保湿霜及其制备方法 | |
CN114177109B (zh) | 一种复合神经酰胺纳米组合物及其制备方法和应用 | |
CN113616561B (zh) | 一种具有保湿修护效果的组合物及化妆品 | |
CN111991305A (zh) | 一种抗皱霜及其制备方法 | |
CN114306165B (zh) | 一种保湿组合物及其制备方法 | |
CN114931543B (zh) | 一种高含量蓝铜胜肽的修护抗衰精华液及制备方法 | |
CN115607499B (zh) | 一种用于抗皱紧致的人参灵芝多肽组合物及其应用 | |
CN115006324B (zh) | 一种含神经酰胺np的滋养修护乳及其制备方法 | |
CN110755288A (zh) | 一种用于皮肤补水保湿的化妆品组合物及其制备方法 | |
CN115192472A (zh) | 一种含有离子液体人源化iii型胶原的美白精华乳及其制备方法 | |
CN113384497B (zh) | 一种双重保湿修复和改善皮肤弹性的组合物及化妆品 | |
CN113143805B (zh) | 一种改善皮肤屏障功能的活性组合物及其制备方法 | |
KR102658915B1 (ko) | 화장료용 멀티 보습제, 이의 제조방법 및 이를 포함하는 화장료 | |
CN116115528B (zh) | 一种舒缓修护保湿组合物及其应用和制备方法 | |
CN112402354A (zh) | 一种滋润保湿乳及其制备方法 | |
CN111419744A (zh) | 一种抗糖化润肤霜及其制备方法 | |
CN112807271B (zh) | 一种保湿组合物、精华液及其制备方法 | |
CN113749972B (zh) | 一种具有抗皱效果的组合物及其在化妆品中的应用 | |
CN110960481A (zh) | 一种增加外泌体产量的护肤品组合物的制备方法 | |
CN115990119A (zh) | 一种抗衰护肤原液及其制备方法和应用 | |
CN114796059A (zh) | 一种保湿修复组合物、护肤品及护肤品制备方法 | |
CN116585224A (zh) | 一种皮肤调理剂及含所述皮肤调理剂的乳液及其制备方法 | |
CN112773732A (zh) | 一种含蚕丝蛋白的滋润修复霜及其制备方法 | |
KR20130062485A (ko) | 제주아그배 추출물을 함유하는 피부 외용제 조성물 | |
CN112618422A (zh) | 复合美白组合物、制备方法及用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201127 |